Literature DB >> 30276748

Proteases: Pivot Points in Functional Proteomics.

Ingrid M Verhamme1, Sarah E Leonard2, Ray C Perkins3.   

Abstract

Proteases drive the life cycle of all proteins, ensuring the transportation and activation of newly minted, would-be proteins into their functional form while recycling spent or unneeded proteins. Far from their image as engines of protein digestion, proteases play fundamental roles in basic physiology and regulation at multiple levels of systems biology. Proteases are intimately associated with disease and modulation of proteolytic activity is the presumed target for successful therapeutics. "Proteases: Pivot Points in Functional Proteomics" examines the crucial roles of proteolysis across a wide range of physiological processes and diseases. The existing and potential impacts of proteolysis-related activity on drug and biomarker development are presented in detail. All told the decisive roles of proteases in four major categories comprising 23 separate subcategories are addressed. Within this construct, 15 sets of subject-specific, tabulated data are presented that include identification of proteases, protease inhibitors, substrates, and their actions. Said data are derived from and confirmed by over 300 references. Cross comparison of datasets indicates that proteases, their inhibitors/promoters and substrates intersect over a range of physiological processes and diseases, both chronic and pathogenic. Indeed, "Proteases: Pivot Points …" closes by dramatizing this very point through association of (pro)Thrombin and Fibrin(ogen) with: hemostasis, innate immunity, cardiovascular and metabolic disease, cancer, neurodegeneration, and bacterial self-defense.

Entities:  

Keywords:  Autoimmune disease; Biomarker development; Cancer; Cardiovascular disease; Cell migration; Cell proliferation; Complement system; Cytosolic proteolysis; DNA processing; DNA repair; DNA replication; Digestion; Drug development; Drug target; Epigenetics; Hemostasis; Immune regulation; Infectious organisms; Inflammation; Intramembrane proteolysis; Intranuclear proteolysis; Metabolic disease; Neurodegenerative disease; Peptidase; Precision medicine; Programmed cell death; Protease; Protease inhibitor; Protease promoter; Protein secretion; Proteolysis; Signaling; Stroke; Transmembrane proteolysis

Mesh:

Substances:

Year:  2019        PMID: 30276748      PMCID: PMC6472488          DOI: 10.1007/978-1-4939-8814-3_20

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  Current Status and Perspectives of Protease Inhibitors and Their Combination with Nanosized Drug Delivery Systems for Targeted Cancer Therapy.

Authors:  Magdalena Rudzińska; Cenk Daglioglu; Lyudmila V Savvateeva; Fatma Necmiye Kaci; Rodolphe Antoine; Andrey A Zamyatnin
Journal:  Drug Des Devel Ther       Date:  2021-01-06       Impact factor: 4.162

2.  Assessment of Proteolysis by Pyrylium and Other Fluorogenic Reagents.

Authors:  Mohamed K Al-Essa; Ebaa Alzayadneh; Kamal Al-Hadidi
Journal:  Protein Pept Lett       Date:  2021       Impact factor: 1.927

Review 3.  Pancreatic Proteolytic Enzymes and Cancer: New Support for an Old Theory.

Authors:  Linda L Isaacs
Journal:  Integr Cancer Ther       Date:  2022 Jan-Dec       Impact factor: 3.077

4.  Inactivation of SARS-CoV-2 and HCoV-229E in vitro by ColdZyme® a medical device mouth spray against the common cold.

Authors:  Ágústa Gudmundsdottir; Reynir Scheving; Fredrik Lindberg; Bjarki Stefansson
Journal:  J Med Virol       Date:  2020-10-14       Impact factor: 20.693

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.